-
Autism Speaks awards $2 million grant to Delivering Scientific Innovation for Autism LLC (DELSIA) for partnership with Seaside Therapeutics to Develop Innovative Autism Treatments | December 3, 2012 #StopBigAutism
Autism Speaks awards $2 million grant to Delivering Scientific Innovation for Autism LLC (DELSIA) for partnership with Seaside Therapeutics to Develop Innovative Autism Treatments DELSIA’s First Award funded by Autism Speaks Supports Development of Arbaclofen and other Innovative Treatments for ASD New York, N.Y. (December 3, 2012) – Autism Speaks and Delivering Scientific Innovation for…
-
Archived | Autism Speaks: Summaries of Funded Studies | Circa 2007 #NotAnAutisticAlly #AutisticHistory
Summaries of Funded Studies (Augmentation and Bridge) “Augmentation” Grants Designed to Supplement or Expand the Scope of Existing Projects In light of a tighter federal research budget, Autism Speaks initiated an “augmentation” funding mechanism designed to supplement or expand the scope of existing NIH and CDC-funded research projects. The additional funds included in these research…
-
Archived | Autism Speaks: MIT Scientists Locate Key Enzyme for Reversing Fragile X in Mice | Circa June 25, 2007 #NotAnAutisticAlly
MIT Scientists Locate Key Enzyme for Reversing Fragile X in Mice Researchers at the Picower Institute for Learning and Memory at the Massachusetts Institute of Technology have located an enzyme in the brain which may lead to an effective therapy for countering the symptoms of Fragile X Syndrome, or FXS. Working with mice which had…